Alliance Pharma plc (APH) — Cash Flow Reinvestment Rate
Alliance Pharma plc (APH) has a Cash Flow Reinvestment Rate of 0.01x as of December 2024, reinvesting GBX113.00K (capex GBX113.00K ) from operating cash flow of GBX20.47 Million. Check Alliance Pharma plc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Alliance Pharma plc Cash Flow Reinvestment Rate (1999–2024)
Historical reinvestment intensity for Alliance Pharma plc across 23 annual periods. Explore Alliance Pharma plc long-term investment allocation to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Alliance Pharma plc (1999–2024)
Year-by-year capital reinvestment analysis for Alliance Pharma plc. For live market cap and broader valuation context, see how much is Alliance Pharma plc worth.
| Year | Reinvestment Rate | Total Reinvested (GBX) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.07x | GBX2.90 Million | GBX38.72 Million | GBX841.00K | ▲ +45.6% |
| 2023 | 0.05x | GBX1.61 Million | GBX31.41 Million | GBX696.00K | ▼ -93.9% |
| 2022 | 0.84x | GBX17.63 Million | GBX20.97 Million | GBX607.00K | ▲ +220.8% |
| 2021 | 0.26x | GBX10.13 Million | GBX38.66 Million | GBX5.53 Million | ▼ -88.0% |
| 2020 | 2.18x | GBX90.48 Million | GBX41.57 Million | GBX4.61 Million | ▲ +1571.3% |
| 2019 | 0.13x | GBX4.66 Million | GBX35.76 Million | GBX4.16 Million | ▼ -43.7% |
| 2018 | 0.23x | GBX5.13 Million | GBX22.17 Million | GBX2.93 Million | ▲ +25.8% |
| 2017 | 0.18x | GBX4.89 Million | GBX26.58 Million | GBX2.69 Million | ▼ -67.0% |
| 2016 | 0.56x | GBX9.43 Million | GBX16.93 Million | GBX1.40 Million | ▼ -96.7% |
| 2015 | 17.11x | GBX136.48 Million | GBX7.98 Million | GBX134.28 Million | ▲ +5508.6% |
| 2014 | 0.31x | GBX3.48 Million | GBX11.42 Million | GBX2.99 Million | ▼ -70.6% |
| 2013 | 1.04x | GBX10.39 Million | GBX10.03 Million | GBX9.89 Million | ▲ +2.6% |
| 2012 | 1.01x | GBX12.56 Million | GBX12.44 Million | GBX12.56 Million | ▲ +29.1% |
| 2011 | 0.78x | GBX6.82 Million | GBX8.72 Million | GBX6.82 Million | ▼ -23.4% |
| 2010 | 1.02x | GBX15.20 Million | GBX14.89 Million | GBX15.20 Million | ▼ -0.7% |
| 2009 | 1.03x | GBX7.91 Million | GBX7.69 Million | GBX7.91 Million | ▲ +248.3% |
| 2008 | 0.30x | GBX772.00K | GBX2.62 Million | GBX772.00K | ▼ -83.4% |
| 2007 | 1.78x | GBX3.03 Million | GBX1.70 Million | GBX3.03 Million | ▼ -66.9% |
| 2005 | 5.37x | GBX1.93 Million | GBX360.00K | GBX1.93 Million | ▼ -57.1% |
| 2003 | 12.54x | GBX12.24 Million | GBX976.00K | GBX12.24 Million | ▲ +127.9% |
| 2001 | 5.50x | GBX110.00K | GBX20.00K | GBX110.00K | ▲ +50.0% |
| 2000 | 3.67x | GBX1.23 Million | GBX336.00K | GBX1.23 Million | ▲ +561.1% |
| 1999 | 0.55x | GBX766.00K | GBX1.38 Million | GBX766.00K | — |